oxandrolone has been researched along with Delayed Puberty in 26 studies
Oxandrolone: A synthetic hormone with anabolic and androgenic properties.
Excerpt | Relevance | Reference |
---|---|---|
"5), with pubertal delay in association with steroid therapy for steroid-sensitive nephrotic syndrome and following renal transplantation were treated with oxandrolone 2." | 7.68 | Oxandrolone for delayed puberty in boys taking long-term steroid therapy for renal disease. ( Chantler, C; Greene, SA; Haycock, GB; Preece, MA; Rees, L; Rigden, SP, 1990) |
"This randomized, placebo-controlled trial demonstrates that low-dose oxandrolone can increase both height and weight velocity in boys with delayed puberty safely." | 5.08 | Oxandrolone therapy in constitutionally delayed growth and puberty. Bio-Technology General Corporation Cooperative Study Group. ( Brown, DR; Dudley, R; McCauley, E; Wilson, DM, 1995) |
"5), with pubertal delay in association with steroid therapy for steroid-sensitive nephrotic syndrome and following renal transplantation were treated with oxandrolone 2." | 3.68 | Oxandrolone for delayed puberty in boys taking long-term steroid therapy for renal disease. ( Chantler, C; Greene, SA; Haycock, GB; Preece, MA; Rees, L; Rigden, SP, 1990) |
"Oxandrolone has an androgenic action as shown by changes in serum LH, testosterone and SHBG concentrations and by the lack of effect on FSH." | 1.29 | The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty. ( Brook, CG; Hindmarsh, PC; Malhotra, A; Poon, E; Pringle, PJ; Tse, WY, 1993) |
"The oxandrolone-treated boys were divided into two groups: four boys who received oxandrolone before onset of puberty (group 2), and 14 boys who started oxandrolone therapy during Tanner stage 2 (group 3)." | 1.29 | The effect of prolonged administration of an anabolic steroid (oxandrolone) on growth in boys with constitutionally delayed growth and puberty. ( Delemarre-van de Waal, HA; Knibbe, P; Schroor, EJ; van Weissenbruch, MM, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (26.92) | 18.7374 |
1990's | 15 (57.69) | 18.2507 |
2000's | 3 (11.54) | 29.6817 |
2010's | 1 (3.85) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Salehpour, S | 1 |
Alipour, P | 1 |
Razzaghy-Azar, M | 1 |
Ardeshirpour, L | 1 |
Shamshiri, A | 1 |
Monfared, MF | 1 |
Gharib, A | 1 |
Zadik, Z | 2 |
Sinai, T | 2 |
Zung, A | 2 |
Reifen, R | 2 |
Borondukov, E | 1 |
Yaniv, I | 1 |
Wilson, DM | 2 |
McCauley, E | 1 |
Brown, DR | 1 |
Dudley, R | 1 |
Albanese, A | 2 |
Stanhope, R | 6 |
Crowne, EC | 2 |
Wallace, WH | 2 |
Moore, C | 2 |
Mitchell, R | 2 |
Robertson, WR | 1 |
Shalet, SM | 3 |
Kelnar, CJ | 2 |
Kewley, GD | 1 |
Long, A | 1 |
Pearl, KN | 1 |
Robins, DG | 1 |
Malhotra, A | 1 |
Poon, E | 1 |
Tse, WY | 2 |
Pringle, PJ | 2 |
Hindmarsh, PC | 3 |
Brook, CG | 6 |
Wu, FC | 1 |
Brown, DC | 1 |
Butler, GE | 1 |
Stirling, HF | 1 |
Schroor, EJ | 1 |
van Weissenbruch, MM | 1 |
Knibbe, P | 1 |
Delemarre-van de Waal, HA | 1 |
Bernasconi, S | 1 |
Street, ME | 1 |
Robertson, WH | 1 |
Holly, JM | 1 |
Cavallo, L | 1 |
Acquafredda, A | 1 |
Zecchino, C | 1 |
Delvecchio, M | 1 |
Buyukgebiz, A | 2 |
Preece, MA | 4 |
Rees, L | 1 |
Greene, SA | 1 |
Rigden, SP | 1 |
Haycock, GB | 1 |
Chantler, C | 1 |
Ulloa-Aguirre, A | 1 |
Blizzard, RM | 2 |
Garcia-Rubi, E | 1 |
Rogol, AD | 2 |
Link, K | 2 |
Christie, CM | 1 |
Johnson, ML | 1 |
Veldhuis, JD | 1 |
Clayton, PE | 1 |
Price, DA | 1 |
Addison, GM | 1 |
Rosenfeld, RG | 1 |
Buchanan, CR | 1 |
Fenn, GC | 1 |
Hindmarsh, P | 1 |
Holownia, P | 1 |
Honour, J | 1 |
Evans, WS | 1 |
Kaiser, DL | 1 |
Parker, MW | 1 |
4 reviews available for oxandrolone and Delayed Puberty
Article | Year |
---|---|
Treatment of the short, sexually immature adolescent boy.
Topics: Adolescent; Anabolic Agents; Growth Disorders; Humans; Male; Oxandrolone; Puberty, Delayed; Testoste | 1994 |
[Benign delayed puberty in boys].
Topics: Adolescent; Anabolic Agents; Antineoplastic Agents, Hormonal; Calcification, Physiologic; Follicle S | 1996 |
Treatment of late puberty.
Topics: Adolescent; Anabolic Agents; Child; Estradiol; Female; Humans; Male; Oxandrolone; Puberty, Delayed; | 1999 |
Treatment of short stature and delayed adolescence.
Topics: Adolescent; Body Height; Child; Female; Growth Disorders; Growth Hormone; Humans; Male; Oxandrolone; | 1987 |
11 trials available for oxandrolone and Delayed Puberty
Article | Year |
---|---|
A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
Topics: Adolescent; Androgens; Aromatase Inhibitors; Body Height; Bone Density; Cholesterol; Double-Blind Me | 2010 |
Vitamin A and iron supplementation is as efficient as hormonal therapy in constitutionally delayed children.
Topics: Adolescent; Analysis of Variance; Androgens; Delayed-Action Preparations; Drug Therapy, Combination; | 2004 |
Longitudinal monitoring of bone accretion measured by quantitative multi-site ultrasound (QUS) of bones in patients with delayed puberty (a pilot study).
Topics: Adolescent; Adolescent Nutritional Physiological Phenomena; Age Determination by Skeleton; Anabolic | 2005 |
Oxandrolone therapy in constitutionally delayed growth and puberty. Bio-Technology General Corporation Cooperative Study Group.
Topics: Adolescent; Anabolic Agents; Child; Double-Blind Method; Growth; Growth Disorders; Humans; Male; Oxa | 1995 |
Degree of activation of the pituitary-testicular axis in early pubertal boys with constitutional delay of growth and puberty determines the growth response to treatment with testosterone or oxandrolone.
Topics: Adolescent; Body Height; Follicle Stimulating Hormone; Fourier Analysis; Growth Hormone; Humans; Lut | 1995 |
Oral treatment for constitutional delay of growth and puberty in boys: a randomised trial of an anabolic steroid or testosterone undecanoate.
Topics: Administration, Oral; Adolescent; Anthropometry; Body Height; Bone Development; Child; Growth Disord | 1994 |
Early morning plasma testosterone is an accurate predictor of imminent pubertal development in prepubertal boys.
Topics: Adolescent; Biomarkers; Child; Circadian Rhythm; Cohort Studies; Follow-Up Studies; Growth Disorders | 1993 |
Effect of low dose oxandrolone and testosterone treatment on the pituitary-testicular and GH axes in boys with constitutional delay of growth and puberty.
Topics: Adolescent; Anabolic Agents; Double-Blind Method; Drug Administration Schedule; Growth Disorders; Gr | 1997 |
Treatment of constitutional delay of growth and puberty with oxandrolone compared with growth hormone.
Topics: Adolescent; Growth Disorders; Growth Hormone; Hormones; Humans; Male; Oxandrolone; Puberty, Delayed | 1990 |
Growth and growth hormone responses to oxandrolone in boys with constitutional delay of growth and puberty (CDGP).
Topics: Adolescent; Child; Growth; Growth Disorders; Growth Hormone; Humans; Insulin-Like Growth Factor I; M | 1988 |
Double blind placebo controlled trial of low dose oxandrolone in the treatment of boys with constitutional delay of growth and puberty.
Topics: Adolescent; Child; Double-Blind Method; Growth Disorders; Humans; Insulin-Like Growth Factor I; Male | 1988 |
11 other studies available for oxandrolone and Delayed Puberty
Article | Year |
---|---|
Predictive factors in the determination of final height in boys with constitutional delay of growth and puberty.
Topics: Adolescent; Analysis of Variance; Anthropometry; Body Height; Child; Growth Disorders; Humans; Male; | 1995 |
The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty.
Topics: Adolescent; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression, Chemical; Fol | 1993 |
The effect of prolonged administration of an anabolic steroid (oxandrolone) on growth in boys with constitutionally delayed growth and puberty.
Topics: Adolescent; Anabolic Agents; Analysis of Variance; Body Height; Case-Control Studies; Growth; Growth | 1995 |
[Constitutional delay of growth and puberty].
Topics: Adolescent; Age Factors; Anabolic Agents; Child; Female; Gonadal Steroid Hormones; Growth Disorders; | 2001 |
Long-term outcome of oxandrolone treatment in boys with constitutional delay of growth and puberty.
Topics: Adolescent; Body Height; Child; Genitalia, Male; Growth Disorders; Humans; Male; Oxandrolone; Pubert | 1990 |
Oxandrolone for delayed puberty in boys taking long-term steroid therapy for renal disease.
Topics: Adolescent; Creatinine; Cyclosporins; Growth; Humans; Kidney Diseases; Kidney Transplantation; Male; | 1990 |
Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency or the GH half-life.
Topics: Adolescent; Circadian Rhythm; Growth Hormone; Half-Life; Humans; Male; Oxandrolone; Puberty, Delayed | 1990 |
Oxandrolone induces a sustained rise in physiological growth hormone secretion in boys with constitutional delay of growth and puberty.
Topics: Adolescent; Body Constitution; Growth Disorders; Growth Hormone; Humans; Luteinizing Hormone; Male; | 1987 |
The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males.
Topics: Adolescent; Child; Circadian Rhythm; Growth Disorders; Growth Hormone; Humans; Insulin-Like Growth F | 1986 |
Oxandrolone in low dose for constitutional delay of growth and puberty in boys.
Topics: Adolescent; Child; Drug Administration Schedule; Growth Disorders; Humans; Male; Oxandrolone; Pubert | 1985 |
Oxandrolone in low dose for constitutional delay of growth and puberty in boys.
Topics: Adolescent; Growth Disorders; Humans; Male; Oxandrolone; Puberty, Delayed; Research Design | 1985 |